CPSC Proposes to Exempt Powder Forms of 2 Drugs from Child-Resistant Packaging
The Consumer Product Safety Commission has issued a proposed rule to amend its child-resistant packaging requirements to exempt powder formulations of two oral prescription drugs, colesevelam hydrochloride (for adults with type 2 diabetes mellitus) and sevelamer carbonate (for chronic kidney…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
disease patients on dialysis), on the basis that child-resistant packaging is not needed to protect young children from serious injury or illness. Comments are due by May 2, 2011.